Central Retinal Artery Occlusion Leading to Diagnosis of Eosinophilic Granulomatous Polyangiitis After Adenovirus Vector COVID-19 Vaccination.
Mary M MosesNathan A FischerCarly ElstonBernard DibPublished in: Journal of vitreoretinal diseases (2024)
Purpose: To present a case of central retinal artery occlusion (CRAO) leading to the diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) within 1 week of an adenovirus vector COVID-19 vaccination. Methods: A case was reviewed. Results: A 50-year-old man with atopic dermatitis and asthma presented with acute painless vision loss in 1 eye. An examination and imaging findings showed CRAO. Further evaluation found eosinophilia and elevated inflammatory markers. A workup for vasculitis showed elevated cytoplasmic-antineutrophil cytoplasmic antibody, perinuclear-antineutrophil cytoplasmic antibody, myeloperoxidase antibody, rheumatoid factor, and total immunoglobulin E. Skin biopsies were consistent with eosinophilic granulomatosis with polyangiitis. Steroids, cyclophosphamide, and mepolizumab were initiated. At 1 year, the patient's systemic symptoms had improved but his vision had not. Conclusions: Few reports exist of CRAO associated with eosinophilic granulomatosis with polyangiitis, with no other instances related to an adenovirus vector COVID-19 vaccination. Treating a systemic vasculitis early can be vision saving in the fellow eye and prevent systemic life-threatening complications.
Keyphrases
- coronavirus disease
- sars cov
- chronic rhinosinusitis
- optical coherence tomography
- atopic dermatitis
- diabetic retinopathy
- drug induced
- case report
- gene therapy
- high resolution
- low dose
- liver failure
- randomized controlled trial
- optic nerve
- high dose
- risk factors
- lung function
- emergency department
- rheumatoid arthritis
- sleep quality
- clinical trial
- interstitial lung disease
- depressive symptoms
- ultrasound guided
- study protocol
- systemic sclerosis
- adverse drug